Understanding HIV Clinical Trials and Why They Matter

Clinical trials are research studies that test how new medicines, treatments, or medical approaches work in real people. For HIV, clinical trials have led to major advances over the past 30 years. Today, people with HIV who take antiretroviral therapy (ART) can live long, healthy lives and may have an undetectable viral load, meaning the virus is suppressed to levels so low it cannot be transmitted to others. This progress happened because people participated in clinical trials.

How to Track Your Driver's License in the Mail →

HIV clinical trials study many different things. Some test new antiretroviral drugs that work better or have fewer side effects than current options. Others study how to prevent HIV in people who do not have it yet, including pre-exposure prophylaxis (PrEP) and other prevention methods. Still others focus on a potential HIV vaccine, ways to cure HIV, or how to treat HIV-related health conditions. Some trials look at how HIV affects specific groups, like pregnant women, older adults, or people of color.

The research process is structured and regulated. The U.S. Food and Drug Administration (FDA) oversees trials to protect participant safety. Every trial has a protocol—a detailed plan describing what will happen, what risks exist, and what benefits might occur. Before any trial begins, an Institutional Review Board (IRB), which includes doctors, ethicists, and community members, reviews the protocol to make sure it is ethical and safe.

Understanding clinical trials matters because trials directly affect treatment options available in your community. If you or someone you know lives with HIV or wants to prevent it, knowing what trials exist and how they work gives you information to make decisions about your own health care.

Practical Takeaway: Clinical trials have transformed HIV from a deadly diagnosis into a manageable condition. Learning about trials helps you understand how new treatments develop and what options may be available to you.

How to Find HIV Clinical Trials in Your Area

Finding HIV clinical trials near you involves searching databases and contacting organizations that maintain current trial information. The most widely used resource is ClinicalTrials.gov, a free database run by the National Institutes of Health (NIH) and the FDA. This website lists over 400,000 clinical trials worldwide, including hundreds of HIV studies. You can search by location, type of trial, and other details to find studies happening in your region.

Learn About DMV Services in Palm Desert California →

To use ClinicalTrials.gov, go to the homepage and select "Search Studies." You can search for "HIV" as the condition and enter your state or city. The results will show trials recruiting in your area, along with basic information about each one. Each trial listing includes the trial name, sponsor, location, contact information, and a brief description of what researchers are studying. The site also shows whether a trial is actively recruiting people or has other status, such as "enrolling by invitation only."

Beyond ClinicalTrials.gov, other resources can help you find trials:

  • The AIDS Clinical Trials Information Service (ACTIS), which is a service from the National Institute of Allergy and Infectious Diseases (NIAID). ACTIS offers phone support at 1-800-TRIALS-A (1-800-874-2572) and maintains lists of HIV trials by region.
  • Local community health centers and federally qualified health centers (FQHCs) often know about trials recruiting in your area and can provide referrals.
  • Your HIV care provider or primary care doctor may have information about trials they work with or recommend.
  • HIV advocacy organizations and community-based organizations (CBOs) in your area frequently have trial information and can connect you with researchers.
  • University medical centers and teaching hospitals often conduct HIV research and maintain trial databases on their websites.

When you find a trial that interests you, contact the study team directly using the information provided. Researchers can tell you more about the trial, explain how it works, and discuss whether it might be right for you. Most trials have staff dedicated to answering questions and explaining the research in plain language.

Practical Takeaway: Start your search on ClinicalTrials.gov or call ACTIS to get a list of trials near you. Write down the contact information for trials that interest you, then reach out directly to learn more.

Types of HIV Clinical Trials and What Each One Studies

HIV clinical trials fall into several categories based on what researchers are studying. Prevention trials test whether new methods can reduce the risk of HIV infection in people who do not have HIV. These include trials of new preventive medicines like long-acting PrEP injections, new vaccines, and behavioral interventions. If you do not have HIV but want to reduce your risk, prevention trials may be relevant to you. Prevention trials have grown significantly in recent years as researchers work toward the goal of an HIV vaccine or improved prevention tools.

Learn Shorthand Writing Techniques For Faster Note Taking →

Treatment trials test new antiretroviral drugs or combinations of drugs. These might study medicines that work differently from current drugs, have fewer side effects, require fewer pills, or work for people whose HIV has resistance to existing drugs. Some treatment trials compare different ways of taking medication, such as daily pills versus injections given once a month or every other month. Others test whether simplified regimens—using fewer drugs—can work as well as current treatments. Treatment trials are important because they lead to more options for people already living with HIV.

Cure and remission trials represent cutting-edge research. These trials study approaches like gene therapy, "shock and kill" strategies (which try to wake up dormant HIV and destroy it), and other experimental methods aimed at eliminating HIV from the body or controlling it without daily medication. These trials are typically complex and may involve more intensive monitoring, but they pursue the possibility of a functional cure—a state where HIV is controlled without ongoing treatment.

Comorbidity trials focus on conditions that often occur alongside HIV, such as cardiovascular disease, cancer, hepatitis C, mental health conditions, or bone health problems. As people with HIV live longer due to effective treatment, managing these other conditions becomes increasingly important. Comorbidity trials help researchers understand how to prevent and treat these issues in people with HIV.

Infrastructure and implementation trials study how to deliver HIV care and prevention more effectively. For example, a trial might test whether text message reminders improve medication adherence, whether telehealth visits work as well as in-person appointments for HIV care, or whether community health workers can effectively deliver prevention services. These trials address real-world challenges in providing HIV services.

Practical Takeaway: Match your situation to trial types: if you want to prevent HIV, look for prevention trials; if you have HIV, look for treatment or management trials; if interested in future cures, search for cure research. Different trials serve different purposes.

What to Expect During an HIV Clinical Trial

Before joining a trial, you will receive detailed information through a process called informed consent. Researchers must provide you with written information describing the trial's purpose, procedures, potential risks, potential benefits, and your rights as a participant. You should receive time to read this document, ask questions, and decide whether to participate. Signing a consent form means you understand what the trial involves and agree to take part. You can always change your mind and leave a trial at any time, for any reason, without affecting your regular medical care.

Learn About Colostomy Bag Care and Cleaning →

Once enrolled, your participation will follow the trial protocol. This might include regular study visits to a clinic, hospital, or research center where staff will perform tests, take blood samples, measure vital signs, and ask questions about your health and any symptoms you experience. The frequency and intensity of visits vary depending on the trial. Some trials require weekly visits; others may require visits monthly or less often. Some trials involve overnight stays in a research unit. You should ask about the time commitment before deciding to participate.

You will receive the study medication or intervention being tested. This might be a pill, injection, infusion, or other form of treatment. Researchers will monitor how your body responds through blood tests, physical exams, and discussions with you about any side effects. If you experience concerning side effects, tell the research team immediately. They can adjust your dose, provide additional support, or discuss whether continuing in the trial is right for you. Some trials provide the study drug at no cost; others may also provide compensation for your time and travel.

Throughout the trial, you will have regular contact with the research team. You might speak with a study nurse, doctor, case manager, or community health worker. These staff members are there to answer questions, monitor your health, and make sure you are safe. Many trials also include community advisory boards—groups of